相关实验视频

Updated: Jun 27, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

超导管大动脉置换与双侧大动脉狭窄的外科大动脉置换-我们需要一个精心设计的随机对照试验

Kendra J Grubb¹, Stephanie K Tom², Joe Xie³

¹Division of Cardiothoracic Surgery, School of Medicine, Emory University, Atlanta, GA 30308, USA.

Journal of clinical medicine

|November 9, 2024

概括

双动脉狭窄症的治疗选择正在不断发展. 虽然通过导管的大动脉置换 (TAVR) 对精选患者有希望,但需要进一步的随机试验来确定患有这种常见心脏状况的年轻人最佳方法.

科学领域:

心脏病学心脏病学
心脏外科手术心脏外科手术
干预心脏病学干预心脏病学

背景情况:

双主动脉狭窄症 (BAS) 是一种流行的心脏病,与三主动脉狭窄症相比,它经常影响年轻患者.
手术性大动脉置换 (SAVR) 一直是BAS的标准治疗方法,特别是当大动脉动脉瘤存在时.
在观察性研究中,通过导管的大动脉置换 (TAVR) 在特定的BAS患者队列中表现出与SAVR相似的结果.

研究的目的:

审查当前关于管理双大动脉狭窄症的证据.
为未来的临床试验提出一个框架,研究TAVR与SAVR在巴斯的研究.
为了解决目前正在进行的关于治疗BAS的治疗设备的问题.

主要方法:

对BAS治疗现有研究的文献综述.
分析TAVR和SAVR结局在双管与三管主动脉疾病.
讨论患者选择标准和试验设计方面的考虑.

主要成果:

对于具有有利BAS解剖的老年患者来说,TAVR是一种合理的选择.
目前在BAS中TAVR的证据主要来自注册表和观测数据.
在年轻的BAS患者中,TAVR的长期疗效和安全性仍在研究中.

结论:

虽然TAVR在选择的BAS患者中是有效的,但强大的随机对照试验对于指导治疗决策至关重要,特别是在年轻,寿命更长的人群中.
未来的试验必须仔细考虑患者的选择和药剂的问题,以最终确定BAS的最佳治疗策略.
最佳的BAS管理需要持续的研究来平衡不同患者人口统计学中的风险和益处.

关键词:

这就是SAVR的原因.在TAVRR中,我们可以看到.双主动脉狭窄症是双主动脉狭窄症.随机对照试验是随机对照试验.

更多相关视频

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement

Published on: January 20, 2022

相关概念视频

Mitral Stenosis III: Medical Management

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...

Aortic Regurgitation III: Medical Management

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...